IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    What the 'return to office' will look like – if there ever is one

    04:43
  • Second victim of the racist mass shooting in Buffalo laid to rest

    00:22
  • Zelenskyy family offers a glimpse of life in Ukraine following war

    02:09
  • Biden arrives in Japan, attempts conversation with Kim Jong Un

    02:17
  • Formula crisis: ‘Operation Fly Formula' bound for Indianapolis

    02:29
  • Jon Hamm talks meeting Tom Cruise on ‘Top Gun: Maverick’ set

    00:47
  • Pete Davidson, Kate McKinnon among those reportedly leaving ‘SNL’

    00:51
  • Pelosi banned from receiving Holy Communion over abortion rights

    00:24
  • Alabama coach Nick Saban apologizes for taking shots at Texas A&M

    02:24
  • Pets find homes after being left behind by Ukrainians fleeing war

    02:08
  • Travelers face summer vacation sticker shock as airline prices soar

    03:15
  • Monkeypox concerns grow as US reports second possible case

    01:58
  • Rudy Giuliani meets with Jan. 6 committee

    00:28
  • Another wild Wall Street week ignites recession fears

    02:01
  • Russia claims complete control of steel plant in Mariupol

    02:23
  • First emergency flights of baby formula expected Sunday

    02:07
  • Biden visits South Korean leader amid threats from Kim Jong-Un

    02:09
  • Heat advisory issued for record warmth in Northeast and Midwest

    01:35
  • Craig Melvin gets fun birthday sendoff from fans in South Carolina

    01:39
  • What's being done to protect sea turtles on Hilton Head Island

    03:46

Dr. Ashish Jha on rising COVID-19 cases, masks, J&J vaccine

04:52

White House COVID-19 response coordinator Ashish Jha joins TODAY to discuss the U.S. surpassing 1 million COVID-related deaths. He also weighs in on case numbers going up and the FDA limiting the use of the J&J vaccine. Dr. Jha says the dangerous sub variant BA.2 is the “primary driver” of the increase of infections.

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk